Navigation Links
Jiangbo Pharmaceuticals Announces Conference Call to Discuss Results for Fourth Quarter Fiscal 2010
Date:9/27/2010

{ var s = ''; var first_result; // Results are keyed by longUrl, so we need to grab the first one. for (var r in data.results) { first_result = data.results[r]; break; } for (var key in first_result) { //s += key + ":" + first_result[key].toString() + "
"; if(key == "shortUrl") { shortURL = first_result[key].toString(); break; } } PostTwitter(); } function readCookie(name){ var cookieValue = ""; var search = name + "="; if(document.cookie.length > 0){ offset = document.cookie.indexOf(search); if (offset != -1){ offset += search.length; end = document.cookie.indexOf(";", offset); if (end == -1) end = document.cookie.length; cookieValue = unescape(document.cookie.substring(offset, end)) } } return cookieValue; } window.onload=function(){ OnNewsreleaseLoad(); var userid = readCookie('DMUserTrack'); var csid = 103849863; var newstogramURL = 'http://www.prnewswire.com/templates/PRN_MultiVu_URL_Reader?userid='+userid+'&csid='+csid; //var newstogramURL ='http://www.prnewswire.com/templates/prnwConfig.xml'; var delay = function() { sendToFlash('StartPlay',newstogramURL); }; setTimeout(delay,100,"JavaScript"); //setTimeout("sendToFlash('StartPlay', 'http://www.prnewswire.com/templates/prnwConfig.xml')",100); }; function ShortenURL() { //Bit.ly function call to shorten url BitlyClient.call('shorten', {'longUrl': formatURL()}, 'BitlyCB.alertResponse'); }

Advanced Search<
'/>"/>

SOURCE Jiangbo Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Jiangbo Pharmaceuticals Reaffirms Guidance for Fiscal 2009
2. Jiangbo Pharmaceuticals to Present at Rodman & Renshaw Annual Global Investment Conference
3. OncoGenex Pharmaceuticals, Inc. - Journal of Clinical Oncology Publishes Data from Randomized Phase 2 Custirsen Trial
4. TOPICA Pharmaceuticals Announces Sublicensing Agreement for Tinea Indication
5. Keryx Biopharmaceuticals to Present at the UBS 2010 Global Life Sciences Conference
6. Optimer Pharmaceuticals Phase 3 Clinical Trials show Fidaxomicin is Superior to Vancomycin in Treatment of Recurrent Clostridium difficile Infection (CDI); Data Presented at ICAAC
7. Edimer Pharmaceuticals and CMC Biologics Announce Agreement to Manufacture EDI200 Recombinant Protein
8. Transdel Pharmaceuticals to Present at Rodman & Renshaw 12th Annual Healthcare Conference
9. Amylin Pharmaceuticals to Present at Morgan Stanley Global Healthcare and Baird Global Healthcare Conferences
10. Access Pharmaceuticals Presents at American Chemical Society Annual Fall Meeting in Boston, MA
11. Xenon Pharmaceuticals Initiates a Phase 2 Clinical Trial in Post Herpetic Neuralgia (PHN) for Topical XEN402.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... ... July 30, 2015 , ... The 2015 Market Research Report on the ... of the global Propanol market with a focus on the Chinese situation. Major companies ... Chemicals, Oxea, ISU Chemical, Sanofi, Royal Dutch Shell, LG Chem and Zhejiang Xinhua Chemical. ...
(Date:7/30/2015)... ... July 30, 2015 , ... ... field clinical study of its canine osteoarthritis stem cell product, currently under development ... City, KS) and will be marketed in the US by Aratana. This product, ...
(Date:7/30/2015)... 30, 2015   Senomyx , Inc. (NASDAQ: ... technologies to discover, develop, and commercialize novel flavor ingredients ... reported financial results for the second quarter 2015. ... we remain on track to achieve our commercial and ... Officer of the Company. "Since our last quarterly earnings ...
(Date:7/30/2015)... , July 30, 2015 Ascendis ... company that applies its innovative TransCon technology to ... top-line results from a six-month Phase 2 study ... TransCon Growth Hormone in 53 treatment-naïve, pre-pubertal children ... "We are extremely pleased with the top-line results ...
Breaking Biology Technology:Global Propanol Market Technical Data and Manufacturing Analysis 2020 2Global Propanol Market Technical Data and Manufacturing Analysis 2020 3VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 2VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 2SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 4SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 5SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 6SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 7SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 8SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 9Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7
... Forensic DNA profiling has become a standard tool ... of mass violence and disaster, but until now there ... the major ethical and policy challenges associated with this ... The National Institutes of Health ...
... CRUCES, N.M., Feb. 2, 2011 Elixir Bio-Tech Inc. ... named one of the top fifty winners of the ... EBT is launching its Algae Biomass Feedstock project ... producing multi-purpose feedstock with ground-breaking Proprietary and Patent Pending ...
... never go to a hospital unless you want to get ... specific airborne virus. The results of a Virginia Tech ... of airborne infection in public places from concentrations of influenza ... issue of the United Kingdom,s Journal of the Royal ...
Cached Biology Technology:CMU Receives $1.2 Million NIH Grant To Develop Ethics, Policy Recommendations for Post-Conflict, Post-Disaster DNA ID Practices 2CMU Receives $1.2 Million NIH Grant To Develop Ethics, Policy Recommendations for Post-Conflict, Post-Disaster DNA ID Practices 3CMU Receives $1.2 Million NIH Grant To Develop Ethics, Policy Recommendations for Post-Conflict, Post-Disaster DNA ID Practices 4Elixir Bio-Tech Inc. Elected One of Top 50 Emerging Companies by 100 Venture Capital Funds & Angel Investors 2Size of airborne flu virus impacts risk, Virginia Tech researchers say 2Size of airborne flu virus impacts risk, Virginia Tech researchers say 3
(Date:7/31/2015)... , 31. Juli 2015 Die 10. internationale Konferenz ... BGI veranstaltet und findet vom 22. bis 25. ... , statt. Die Konferenz feiert ... Start 2006 ist die ICG weltweit zu einem ... Sie ist eines der dynamischsten, enthusiastischsten und angenehmsten ...
(Date:7/30/2015)... , July 30, 2015 Cellecta, ... for gene function analysis and biomarker discovery, announced ... (sgRNA) Knockout Library targeting all human protein coding ... permanently "knock out" a gene,s function. Cellecta,s new ... high throughput screening tool so that researchers can ...
(Date:7/23/2015)... BEDFORD, Mass., July 23, 2015 Aware, Inc. (NASDAQ: ... services, today reported financial results for its second quarter ended ... quarter of 2015 was $4.5 million, a decrease of 33% ...  Net income in the second quarter of 2015 was $0.3 ... million, or $0.04 per diluted share, in the same period ...
Breaking Biology News(10 mins):Die 10. internationale Konferenz zu Genomik (ICG-10) beginnt im Oktober 2Die 10. internationale Konferenz zu Genomik (ICG-10) beginnt im Oktober 3CELLECTA, INC. Announces Launch of Human Whole Genome CRISPR Knockout Library 2Aware, Inc. Reports Second Quarter 2015 Financial Results 2Aware, Inc. Reports Second Quarter 2015 Financial Results 3Aware, Inc. Reports Second Quarter 2015 Financial Results 4Aware, Inc. Reports Second Quarter 2015 Financial Results 5Aware, Inc. Reports Second Quarter 2015 Financial Results 6
... A recent Genomed-Health 2005 workshop in Tunisia, supported ... the life sciences in improving health in countries ... also discussed the importance of Euro-Mediterranean partnerships in ... life sciences ?in particular following the mapping of ...
... "programmed" cells to make their own contrast agents, enabling ... appearing in the April issue of Nature Medicine, hold ... field of molecular therapeutics and for monitoring the delivery ... it has been the chemist's job to develop agents ...
... cancer treatment - targeted radiotherapy, on a cellular scale. Antibodies ... kill cancerous cells. Provided that you can find something different ... is not as easy as it sounds. , A ... of the time of traditional chemotherapy with fewer side effects ...
Cached Biology News:Measuring the impact of post-genomics on Mediterranean populations 2Carnegie Mellon scientists develop tool that uses MRI to visualize gene expression in living animals 2New Treatment Rivals Chemotherapy For Lymphoma, Study Finds 2New Treatment Rivals Chemotherapy For Lymphoma, Study Finds 3
... exciting product for cell-based kinetic assays and ... use of expensive HTS equipment, which lead ... assay development stage. The NOVOstar offers the ... well as any other assay suitable for ...
... Identical to the DH-2000, but comes with ... switch up to 5 Hz) The ... the continuous spectrum of deuterium and tungsten halogen ... combined-spectrum light source produces a powerful, stable output ...
... dispensers save space and organize gloves, ... garb. They are the perfect benchtop ... in labs, processing and manufacturing. Clear ... the particles they attract. Open-slot design ...
... degradation is critical to the maintenance ... regulatory proteins as important and diverse ... heat shock and stress response, antigen ... and ion channels, cell cycle regulation, ...
Biology Products: